Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Thursday 09 November, 2017

GlaxoSmithKline PLC

Block listing Interim Review

RNS Number : 1021W
GlaxoSmithKline PLC
09 November 2017
 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - Ordinary Shares

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

4,104,101

 

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

543,609

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

3,559,772

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 



 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline Share Option Plan - ADS

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

8,795,814

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

611,414

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

8,185,120

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 



 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Wellcome UK Share Option Scheme

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

5,119,750

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

5,119,750

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 



 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Wellcome International Share Option Scheme

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

13,267,156

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

13,267,156

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 



 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

Glaxo Wellcome 1999 Share Option Plan

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

1,040,000

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,040,000

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 



 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

163,606

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

163,606

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 



 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

275,420

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

275,420

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 



 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

100,000

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

100,000

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 



 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2012

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

1,635,325

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

93,255

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,542,070

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 09 November 2017

 

Name of applicant:

GlaxoSmithKline plc

Name of scheme:

GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan

Period of return:

From:

1 May 2017

To:

31 October 2017

Balance of unallotted securities under scheme(s) from previous return:

200,071

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

989

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

199,082

 

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRKMMGMVLLGNZM

a d v e r t i s e m e n t